Rona Limor

Title: Rona Limor: Innovator in Adipocyte-Specific Constructs

Introduction

Rona Limor is a prominent inventor based in Herzliya, Israel. She has made significant contributions to the field of medical research, particularly in the area of obesity and adipose tissue modulation. With a total of 2 patents, her work focuses on innovative methods to address conditions associated with excess fat cell mass.

Latest Patents

Rona Limor's latest patents include groundbreaking inventions related to adipocyte-specific constructs and methods for inhibiting platelet-type 12 lipoxygenase expression. These inventions are directed towards constructs, compositions, and methods for modulating platelet-type 12 lipoxygenase (12-LO) in adipose tissue in vivo. Specifically, her inventions provide constructs encoding expression-inhibiting oligonucleic acids, such as antisense and RNA interfering (RNAi) molecules, targeted to a platelet-type 12-LO gene or transcript. These constructs are capable of reducing or silencing platelet-type 12-LO expression specifically in adipocytes and pre-adipocytes. The patents also encompass vectors comprising these constructs, including viral vectors, and methods for treating conditions associated with obesity.

Career Highlights

Rona Limor is affiliated with the Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center. Her work has been instrumental in advancing research in the medical field, particularly in understanding and treating obesity-related conditions.

Collaborations

Rona has collaborated with notable colleagues, including Gary Weisinger and Naftali Stern, contributing to a rich environment of innovation and research.

Conclusion

Rona Limor's contributions to the field of medical research through her patents and collaborations highlight her role as a leading inventor in the fight against obesity. Her innovative approaches continue to pave the way for advancements in health and medical treatments.